Be smarter and faster with PRO Alerts on EAPH
Reevaluating The Schwag: Easton Pharmaceuticals, Still Schwag
- EAPH continues reports that it "has not generated material revenues from the sale of products".
- With limited cash, the company has threatened to file a lawsuit against a "certain Seeking Alpha writer," most likely using the paid-in capital from this past year.
- The company announced that it had gained the exclusive option to purchase up to 49% of a private MMPR grower with a 5,000 sq ft. facility.
- FINRA has halted several marijuana stocks the past few months, causing a major correction for pot stocks. The overall marijuana stock market has dropped over 50% in value.
There are no Transcripts on EAPH.
Fri, Mar. 28, 11:05 AM| 1 Comment
EAPH vs. ETF Alternatives
Other News & PR